Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Should Vaccine Makers Ever Be Liable For Design Defects? Supreme Court Amicus Briefs Argue Question

Executive Summary

Vaccine manufacturers, the federal government and several scientists, including Nobel Laureate James Watson, asked the U.S. Supreme Court to uphold an appeals court ruling that shields companies from liability for alleged vaccine design defects

You may also be interested in...

Supreme Court Justices Question Role Of Comparative Safety Assessments In Vaccine Liability Case

In Bruesewitz v Wyeth oral arguments, high court weighs whether the National Childhood Vaccine Injury Act preempts all design defect claims against manufacturers.

Supreme Rx: 340B Pricing, Baycol Class Action To Get High Court Review

The court will consider whether health care providers have the right to file suit to get drug manufacturers to enforce statutory requirements on drug pricing.

Vaccine Liability Question Is Urgent, Gov't. Says; Supreme Court Takes Up Case

At the encouragement of the government, the U.S. Supreme Court agreed to take up the question of whether a federal law shields vaccine manufacturers from all liability for alleged vaccine design defects

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts